Bliss GVS Pharma shareholding pattern
BLISSGVS
170.51
0.01 (0.01%)Last updated on 2 Feb, 2026 | 10:57 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Summary
For Year 2025-26, Bliss GVS Pharma reports the following shareholding: Total Promoters at 35.36%, Mutual Fund at 0%, Insurance at 5.78%, Foreign Institutional Investors at 14.54%, Domestic Institutional Investors at 0%, and Retail at 44.32%. This breakdown provides a quick snapshot of ownership distribution for Bliss GVS Pharma in 2025-26.
Bliss GVS Pharma FAQs
As of 02-2026, the promoter shareholding in Bliss GVS Pharma stands at 35.36% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Bliss GVS Pharma is 14.54% and 0% respectively.
The retail shareholding of the Bliss GVS Pharma is 44.32%.
Changes in shareholding patterns of Bliss GVS Pharma can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Bliss GVS Pharma are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
